Cargando…
Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α
The blood–brain tumor barrier represents a major obstacle for anticancer drug delivery to brain tumors. Thus, novel strategies aimed at targeting and breaching this structure are of great experimental and clinical interest. This review is primarily focused on the development and use of a derivative...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315592/ https://www.ncbi.nlm.nih.gov/pubmed/35890309 http://dx.doi.org/10.3390/pharmaceutics14071414 |